Cargando…

Possible pharmacogenetic factors in clozapine treatment failure: a case report

There is still much to learn about the predictors of therapeutic response in psychiatry, but progress is gradually being made and precision psychiatry is an exciting and emerging subspeciality in this field. This is critically important in the treatment of refractory psychotic disorders, where cloza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whiskey, Eromona, Romano, Graziella, Elliott, Matilda, Campbell, Malcolm, Anandarajah, Cholan, Taylor, David, Valsraj, Koravangattu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862186/ https://www.ncbi.nlm.nih.gov/pubmed/35211290 http://dx.doi.org/10.1177/20451253211030844

Ejemplares similares

Resolution without discontinuation: heart failure during clozapine treatment
por: Whiskey, Eromona, et al.
Publicado: (2020)

Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
por: Keshavarzi, Farinaz, et al.
Publicado: (2020)

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
por: Rodriguez, Victoria, et al.
Publicado: (2020)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
por: Green, Alastair, et al.
Publicado: (2019)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
por: Livermore, Cecilia, et al.
Publicado: (2022)

Modelling admission lengths within psychiatric intensive care units
por: Dye, Stephen, et al.
Publicado: (2023)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Understanding geopolitical determinants of health
por: Persaud, Albert, et al.
Publicado: (2021)

Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

A Case Study Using a Behavioural Contract in Alcohol Dependence within a Crisis Home Treatment Team
por: Howe, Andrew John, et al.
Publicado: (2022)

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
por: Verbelen, M, et al.
Publicado: (2015)

Call for Action to Address Equity and Justice Divide During COVID-19
por: Bhaskar, Sonu, et al.
Publicado: (2020)

Rehabilitation or Stagnation? a Six Month Mirror-Image Study Reviewing the Effectiveness of an Inpatient Rehabilitation Unit
por: Kapila, Adisha, et al.
Publicado: (2022)

Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19
por: Dragoi, Ana Miruna, et al.
Publicado: (2020)

Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK
por: Ninomiya, Kohei, et al.
Publicado: (2021)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
por: Lowe, Penelope, et al.
Publicado: (2017)

Clozapine-induced cardiac failure
por: Thomas, Kuruvilla, et al.
Publicado: (2006)

Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals
por: Oloyede, Ebenezer, et al.
Publicado: (2021)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Clozapine-associated renal failure: A case report and literature review
por: Davis, Erica A. K., et al.
Publicado: (2019)

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine
por: Girardin, François R., et al.
Publicado: (2018)

Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series
por: Šimičević, Livija, et al.
Publicado: (2023)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
por: Casetta, Cecilia, et al.
Publicado: (2020)

A Case of Clozapine Induced Acute Renal Failure
por: An, Na Young, et al.
Publicado: (2013)

Clozapine: Drowsiness with markedly increased hypersalivation and myoclonus secondary to clozapine toxicity: case report
Publicado: (2021)

Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration
por: Liu, Taixiu, et al.
Publicado: (2023)

Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines
por: Shakur, Rameen, et al.
Publicado: (2011)

Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
por: Richardson, Marty, et al.
Publicado: (2019)

Clozapine: Various toxicities: case report
Publicado: (2021)

Clozapine and Sweet's syndrome: case report
por: Bunting, Apphia, et al.
Publicado: (2023)

Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report
por: Yartsev, Alex, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38cosfok96joln3egmjm9t3tif